Lymphoma T Cell clinical trials

Explore recruiting lymphoma t cell clinical trials.

Recruiting lymphoma t cell studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lymphoma T Cell trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A safety study of PF-08046044/SGN-35C in adults with advanced cancers

France, Spain, Denmark, Germany, Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1/2, Open-Label, Multicenter Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Fadraciclib (CYC065), an Oral CDK2/9 Inhibitor, in Subjects with Advanced Solid Tumors and Lymphoma.

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Phase 1, open-label, multicenter, dose escalation study of SRG-1505 as monotherapy in subjects with mature b-cell malignancies

France, Poland, Romania, Italy, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Lymphoma T Cell trials by city

Lymphoma T Cell in Toronto Lymphoma T Cell in Vancouver Lymphoma T Cell in Montreal Lymphoma T Cell in Calgary Lymphoma T Cell in Edmonton Lymphoma T Cell in Ottawa Lymphoma T Cell in Winnipeg Lymphoma T Cell in Quebec City Lymphoma T Cell in Hamilton Lymphoma T Cell in Kitchener Lymphoma T Cell in London Lymphoma T Cell in Halifax Lymphoma T Cell in New York Lymphoma T Cell in Los Angeles Lymphoma T Cell in Chicago Lymphoma T Cell in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease